圣湘生物: 圣湘生物科技股份有限公司2025年半年度报告摘要

Core Points - The company plans to distribute a cash dividend of 2.62 yuan per 10 shares to all shareholders, with no capital reserve conversion or bonus shares [1] - As of the end of the reporting period, the total assets of the company reached approximately 9.52 billion yuan, reflecting a year-on-year increase of 10.65% [2] - The company's operating revenue for the reporting period was approximately 868.62 million yuan, representing a year-on-year growth of 21.15% [2] - The total profit for the period was approximately 170.61 million yuan, showing a slight increase of 1.37% compared to the previous year [2] - The net profit attributable to shareholders of the listed company was approximately 135.89 million yuan, which is a 12.19% increase compared to the same period last year [2] - The company reported a negative cash flow from operating activities of approximately -142.85 million yuan [2] - The basic earnings per share for the period was 0.28 yuan, compared to 0.27 yuan in the previous year [3] - The company invested approximately 153.82 million yuan in research and development, which accounted for a certain percentage of its operating revenue [3] - The total number of shareholders at the end of the reporting period was 20,774 [3]